Your browser doesn't support javascript.
loading
Oral Semaglutide in the Management of Type 2 DM: Clinical Status and Comparative Analysis.
Bandyopadhyay, Ilora; Dave, Sunny; Rai, Amita; Nampoothiri, Madhavan; Chamallamudi, Mallikarjuna Rao; Kumar, Nitesh.
Afiliación
  • Bandyopadhyay I; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
  • Dave S; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
  • Rai A; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
  • Nampoothiri M; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka,India.
  • Chamallamudi MR; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka,India.
  • Kumar N; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal-576104, Karnataka, India.
Curr Drug Targets ; 23(3): 311-327, 2022.
Article en En | MEDLINE | ID: mdl-34468297

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Revista: Curr Drug Targets Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Emiratos Árabes Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Límite: Humans Idioma: En Revista: Curr Drug Targets Asunto de la revista: TERAPIA POR MEDICAMENTOS Año: 2022 Tipo del documento: Article País de afiliación: India Pais de publicación: Emiratos Árabes Unidos